Advanced pediatric inoperable thymus carcinoma (type C thymoma): Case report on a novel therapeutic approach

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 11, 2007, Pages 774-775

  Kertesz, Gabriella P ^a,b   Hauser, Peter ^a   Varga, Peter ^a   Dabasi, Gabriella ^b   Schuler, Dezso ^a   Garami, Miklos ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Octreoscan; Octreotide; Prednisolone; Thymic carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMATINIB; OCTREOTIDE; PREDNISOLONE; SOMATOSTATIN RECEPTOR 2; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; COUGHING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; THYMUS CANCER; TREATMENT DURATION; WEIGHT REDUCTION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; OCTREOTIDE; PREDNISOLONE; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 35948939340     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318159a535     Document Type: Article

References (10)

1. Takeda S, Sawabata N, Inoue M, et al. Thymic carcinoma. Clinical institutional experience with 15 patients. Eur J Cardiothorac Surg. 2004;26:401-406.
2. Lucchi M, Mussi A, Basolo F, et al. The multimodality treatment of thymic carcinoma. Eur J Cardiothorac Surg. 2001;19:566-569.
3. Frazier AA, Garcia G, Monge JG, et al. 2002. Available at: http://www.thymoma.de/thymoma//extended/body.html. Accessed August 20, 2006.
4. Marino M, Muller-Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol. 1985;407:119-149.
5. Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg. 1999;230:562-572. Discussion 564-572.
6. Carlson RW, Dorfman RF, Sikic BI. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy. Cancer. 1990;66:2092-2094.
7. Palmieri G, Lastoria S, Colao A, et al. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med. 1997;336:263-265.
8. Palmieri G, Montella L, Martignetti A, et al. Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer. 2002;94:1414-1420.
9. Loehrer PJ Jr, Wang W, Johnson DH, et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol. 2004;22:293-299.
10. Fuller PJ, Verity K. Somatostatin gene expression in the thymus gland. J Immunol. 1989;143:1015-1017.